Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1189

1.
2.

The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.

Du T, Cheng J, Zhong L, Zhao XF, Zhu J, Zhu YJ, Liu GH.

Cytotherapy. 2012 Nov;14(10):1215-27. doi: 10.3109/14653249.2012.711471. Epub 2012 Aug 27.

PMID:
22920838
3.

Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction.

Ju GQ, Cheng J, Zhong L, Wu S, Zou XY, Zhang GY, Gu D, Miao S, Zhu YJ, Sun J, Du T.

PLoS One. 2015 Mar 20;10(3):e0121534. doi: 10.1371/journal.pone.0121534. eCollection 2015.

4.

Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.

Zou X, Zhang G, Cheng Z, Yin D, Du T, Ju G, Miao S, Liu G, Lu M, Zhu Y.

Stem Cell Res Ther. 2014 Mar 19;5(2):40. doi: 10.1186/scrt428.

5.

Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.

Wu HJ, Yiu WH, Li RX, Wong DW, Leung JC, Chan LY, Zhang Y, Lian Q, Lin M, Tse HF, Lai KN, Tang SC.

PLoS One. 2014 Mar 19;9(3):e90883. doi: 10.1371/journal.pone.0090883. eCollection 2014.

6.

Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.

Chang JW, Tsai HL, Chen CW, Yang HW, Yang AH, Yang LY, Wang PS, Ng YY, Lin TL, Lee OK.

J Cell Mol Med. 2012 Dec;16(12):2935-49. doi: 10.1111/j.1582-4934.2012.01610.x.

7.

Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.

Cóndor JM, Rodrigues CE, Sousa Moreira Rd, Canale D, Volpini RA, Shimizu MH, Camara NO, Noronha Ide L, Andrade L.

Stem Cells Transl Med. 2016 Aug;5(8):1048-57. doi: 10.5966/sctm.2015-0138. Epub 2016 Jun 8.

8.

Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.

Zhang A, Wang MH, Dong Z, Yang T.

Am J Physiol Renal Physiol. 2006 Dec;291(6):F1323-31. Epub 2006 Jul 25.

9.

Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.

Wang HY, Wang YJ, Cui MJ, Gu CM, Yang LZ, Zhao Y, Chen Y, Zhao D, Li TS, Chi BR.

Indian J Biochem Biophys. 2011 Oct;48(5):308-15.

PMID:
22165288
10.

Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats.

Yu Y, Lu L, Qian X, Chen N, Yao A, Pu L, Zhang F, Li X, Kong L, Sun B, Wang X.

Stem Cells Dev. 2010 Jun;19(6):903-14. doi: 10.1089/scd.2009.0254.

PMID:
20025519
12.

Albumin-induced epithelial mesenchymal transformation.

Ibrini J, Fadel S, Chana RS, Brunskill N, Wagner B, Johnson TS, El Nahas AM.

Nephron Exp Nephrol. 2012;120(3):e91-102. doi: 10.1159/000336822. Epub 2012 May 16.

PMID:
22613868
13.

BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells.

Dudas PL, Argentieri RL, Farrell FX.

Nephrol Dial Transplant. 2009 May;24(5):1406-16. doi: 10.1093/ndt/gfn662. Epub 2008 Dec 4.

PMID:
19056781
14.

Micro-vesicles derived from human Wharton's Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation.

Wu X, Yan T, Wang Z, Wu X, Cao G, Zhang C, Tian X, Wang J.

J Cell Biochem. 2018 Feb;119(2):1879-1888. doi: 10.1002/jcb.26348. Epub 2017 Sep 7.

PMID:
28815768
15.

V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells.

Cao X, Yang Q, Qin J, Zhao S, Li X, Fan J, Chen W, Zhou Y, Mao H, Yu X.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1121-32. doi: 10.1152/ajprenal.00278.2011. Epub 2011 Nov 30.

16.

Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.

Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y, Doi T, Higashi Y, Yorioka N, Kato Y, Kohno N, Masaki T.

Kidney Int. 2013 Aug;84(2):297-307. doi: 10.1038/ki.2013.81. Epub 2013 Mar 13.

18.
19.

β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.

Zhang W, Miao J, Ma C, Han D, Zhang Y.

Peptides. 2012 Aug;36(2):186-91. doi: 10.1016/j.peptides.2012.05.022. Epub 2012 Jun 9.

PMID:
22687367
20.

Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.

Qi S, Wu D.

Int J Mol Med. 2013 Dec;32(6):1262-72. doi: 10.3892/ijmm.2013.1517. Epub 2013 Oct 8.

Supplemental Content

Support Center